SecBot SecBot
Institutional Cluster

ACH

ACCENDRA HEALTH INC/VA/
MIXED
Impact 5/10
Horizonweeks Processed2mo ago
Institutional cluster: 8 buyers, 4 sellers (mixed)
Actionable Insight ◆ Mixed

A mixed institutional cluster for Accendra Health in Q2 2026 shows 8 buyers accumulating $1.7M in new positions (led by Citadel, Wells Fargo, and Russell Investments) while 4 sellers trimmed $644K (led by Dimensional Fund Advisors and UBS). The buying is dominated by active asset managers and a quant fund, suggesting a contrarian bet on the company's post-restructuring story, but the lack of insider buying and the company's ongoing revenue decline from a large commercial payer exit temper conviction. The cluster follows a bearish Q2 earnings report (revenue -10.1% YoY, GAAP loss) and CEO retirement announcement, making this a high-conviction institutional divergence with uncertain near-term catalysts.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
ACH ▲ +3.74% at T+20d
NEUTRAL call +3.74% · α vs SPY +5.72% · entry $1.07 → $1.11
Next anchor: T+60d in 13d
Latest observation: T+46 -25.17% FF3 residual α
Entry = T+0 close
Aug 16, 2026
via day close
T+1d
+5.61%
call +5.61% · α +6.28%
$1.13
settled 2mo ago
T+5d
+8.41%
call +8.41% · α +9.60%
$1.16
settled 2mo ago
T+20d
+3.74%
call +3.74% · α +5.72%
$1.11
settled 6w ago
T+60d
Pending
in 13d

Executive Summary

A mixed institutional cluster for Accendra Health in Q2 2026 shows 8 buyers accumulating $1.7M in new positions (led by Citadel, Wells Fargo, and Russell Investments) while 4 sellers trimmed $644K (led by Dimensional Fund Advisors and UBS). The buying is dominated by active asset managers and a quant fund, suggesting a contrarian bet on the company's post-restructuring story, but the lack of insider buying and the company's ongoing revenue decline from a large commercial payer exit temper conviction. The cluster follows a bearish Q2 earnings report (revenue -10.1% YoY, GAAP loss) and CEO retirement announcement, making this a high-conviction institutional divergence with uncertain near-term catalysts.

Key Financial Metrics

Direction
mixed
Buy Value
$1.7M
Sell Value
$643.7K
Net Flow
$1.1M

Institutional Positions

Net institutional flow: $1.1M

▲ Buyers (8)

InstitutionActionChangePosition ValueValue Δ
CitadelADD+64.4%$1.3M$786.0K
Wells FargoDOUBLED+278.6%$543.0K$447.0K
Russell Investments GroupDOUBLED+149.2%$195.0K$143.0K
Imc-ChicagoDOUBLED+129.1%$145.0K$102.0K
CitigroupDOUBLED+437%$116.0K$102.0K

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Dimensional Fund AdvisorsTRIM-37.1%$5.9M-$333.7K
UBSTRIM-69.4%$704.0K-$381.1K
Morgan StanleyTRIM-27.6%$968.0K$84.0K
Walleye CapitalTRIM-64.3%$27.0K-$12.7K

Key Facts

  • 8 institutional buyers added $1.7M in new positions vs 4 sellers trimming $644K in Q2 2026
  • Top buyer Citadel added 64.4% more shares ($786K increase); Wells Fargo doubled its position ($447K increase)
  • Top seller Dimensional Fund Advisors trimmed 37.1% of its stake ($334K reduction); UBS cut 69.4% ($381K reduction)
  • Cluster follows Q2 2026 earnings: revenue $613.2M (-10.1% YoY), GAAP loss $89.1M, CEO retirement announced
  • No insider open-market buying in the window (confluence score 31/100, verdict 'institutions_only')
  • Active managers dominate the buying side (7 of 8 buyers are asset managers or quant funds), not passive rebalancing

Financial Impact

Net institutional buying of approximately $1.1M (8 buyers added $1.7M, 4 sellers removed $644K) against a $73M market cap

institutional_ownershipfloat_percentage

Risk Factors

  • Revenue continues to decline from large commercial payer exit (-10.1% YoY in Q2 2026)
  • CEO retirement creates leadership uncertainty
  • No insider buying to corroborate institutional conviction
  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • Analyst consensus is 78% bearish (12 of 13 analysts rate Hold or Sell)

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Analyst Consensus
8% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ACH-2026-Q2
15 reports for ACH
Performance horizon
100% Hit rate @ T+5 6 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +62.31%Jun 11, 2026
Filters
Rows
Reports for ACH — sortable, filterable
TypeNow
Oct 9, 2026
17d ago
8-K
BEARISH ★ 7/10
$0.3905 $0.2202▲ +43.61%▲ +42.12%—
Oct 7, 2026
19d ago
SC 13G
NEUTRAL ★ 4/10
$0.4729 $0.3128▼ −33.85%▼ −32.87%—
Sep 17, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$1.03 $0.7332▼ −28.82%▼ −29.42%—
Aug 17, 2026
10w ago
8-K
BULLISH ★ 5/10
$1.07 $1.16▲ +8.41%▲ +9.60%—
Aug 16, 2026
10w ago
Institutional Cluster
MIXED ★ 5/10
$1.07 $1.16▲ +8.41%▲ +9.60%—
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$1.26 $1.13▼ −10.32%▼ −9.91%—
Aug 10, 2026
11w ago
8-K
BEARISH ★ 6/10
$1.40 $1.07▲ +23.57%▲ +23.52%—
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 3/10
$1.40 $1.07▼ −23.57%▼ −23.52%—
Jul 27, 2026
13w ago
EFFECT
NEUTRAL ★ 3/10
$3.22 $3.41▲ +5.90%▲ +3.39%—
Jun 25, 2026
17w ago
8-K
NEUTRAL ★ 5/10
$3.34 $3.59▲ +7.49%▲ +5.32%—
Showing 10 of 15

US Market Status

Market Open — Closes in 6h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 16, 2026